Table 6.
Polymorphism | Genotype | N = 300 (%) | Survival Rate (%) | p-Value 2,* | ||
---|---|---|---|---|---|---|
1-Year LSCC 1-Specific Survival (%) | 3-Year LSCC 1-Specific Survival (%) | 5-Year LSCC 1-Specific Survival (%) | ||||
IL-9 rs1859430 | AA | 17 (5.7) | 88 | 45 | 45 | 0.188 0.026 ** |
AG | 95 (31.7) | 81 | 74 | 69 | ||
GG | 188 (62.6) | 85 | 71 | 65 | ||
IL-9 rs2069870 | AA | 191 (63.7) | 84 | 71 | 64 | 0.853 |
AG | 109 (63.7) | 83 | 68 | 66 | ||
IL-9 rs1174113 | CC | 210 (70.0) | 85 | 71 | 65 | 0.619 |
CT | 81 (27.0) | 79 | 67 | 64 | ||
TT | 9 (3.0) | 100 | 76 | 76 | ||
IL-9 rs2069885 | AA | 9 (3.0) | 100 | 76 | 76 | 0.640 |
GA | 78 (26.0) | 79 | 67 | 64 | ||
GG | 213 (71.0) | 85 | 71 | 65 | ||
IL-9 rs2069884 | GG | 213 (71.0) | 85 | 71 | 65 | 0.640 |
GT | 782 (26.0) | 79 | 67 | 64 | ||
TT | 9 (3.0) | 100 | 76 | 76 |
1 LSCC: laryngeal squamous cell carcinoma; 2 p-Value: significance level p < 0.05; * Gehan’s criterion; ** AA vs. AG and GG.